Drawing for COMMITTED TO YOUR MISSION

USPTO serial 99774078

COMMITTED TO YOUR MISSION

Reviewed by CopyMark Law Group

Reg. 8501035Status 700Registered
Filing date
Status date
Registration date
Oct 13, 2026
Examiner
BRECKENFELD, WILLIAM G
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COMMITTED TO YOUR MISSION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Tiffani D. Otey

Tiffani D. Otey KILPATRICK TOWNSEND & STOCKTON LLP1001 West Fourth StreetWinston-Salem, NC 27101United States

Goods and services

ClassDescriptionStatusFirst use
035Business services, namely, business management and consulting services in the field of clinical trials and drug development; business administration of clinical trials for others; outsourcing services in the nature of arranging procurement of clinical research services for others; business data management and business project management services in the field of healthcare and life sciences; patient recruitment and management services for clinical studiesACTIVEFeb 11, 2026
042Scientific and technological services, namely, clinical research services for others; contract research organization (CRO) services in the field of pharmaceuticals, biotechnology, and medical devices; design and development of clinical trials; clinical trial management services; providing scientific research and analysis in the fields of drug development, biopharmaceuticals, and healthcare; regulatory compliance consulting in the field of clinical research; data management and statistical analysis for clinical trials; laboratory research services; and providing temporary use of non-downloadable software for managing and analyzing clinical trial dataACTIVEFeb 11, 2026
044Medical and healthcare services, namely, conducting clinical trials for others; medical testing for diagnostic or treatment purposes; patient recruitment and management services for clinical studies; providing medical information in the field of pharmaceuticals and clinical researchACTIVEFeb 11, 2026

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Oct 13, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 25, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 25, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 19, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 27, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 27, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jul 27, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Jul 27, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Jul 27, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 21, 2026DOCKASSIGNED TO EXAMINER—
Apr 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 20, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 20, 2026NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance